Randomised phase II trial of pegylated liposomal doxorubicin (Doxilâ/Caelyxâ) versus doxorubicin in the treatment of advanced or metastatic soft tissue sarcoma: a study by the EORTC Soft Tissue and Bone Sarcoma Group

I Judson; JA Radford; M Harris; JY Blay; Q van Hoesel; A le Cesne; AT van Oosterom; MJ Clemons; C Kamby; C Hermans; J Whittaker; E Donato di Paola; Jaap Verweij; S Nielsen

Randomised phase II trial of pegylated liposomal doxorubicin (Doxilâ/Caelyxâ) versus doxorubicin in the treatment of advanced or metastatic soft tissue sarcoma: a study by the EORTC Soft Tissue and Bone Sarcoma Group

I Judson, JA Radford, M Harris, JY Blay, Q van Hoesel, A le Cesne, AT van Oosterom, MJ Clemons, C Kamby, C Hermans, J Whittaker, E Donato di Paola, Jaap Verweij, S Nielsen

Medical Oncology

Research output: Contribution to journal › Article › Academic › peer-review

344 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	870-877
Number of pages	8
Journal	European Journal of Cancer
Volume	37
Publication status	Published - 2001

Research programs

EMC MM-03-86-08

Cite this

Judson, I., Radford, JA., Harris, M., Blay, JY., van Hoesel, Q., le Cesne, A., van Oosterom, AT., Clemons, MJ., Kamby, C., Hermans, C., Whittaker, J., Donato di Paola, E., Verweij, J., & Nielsen, S. (2001). Randomised phase II trial of pegylated liposomal doxorubicin (Doxilâ/Caelyxâ) versus doxorubicin in the treatment of advanced or metastatic soft tissue sarcoma: a study by the EORTC Soft Tissue and Bone Sarcoma Group. European Journal of Cancer, 37, 870-877.

@article{5514d85394f148318eca600c7f21c1cc,

title = "Randomised phase II trial of pegylated liposomal doxorubicin (Doxil{\^a}/Caelyx{\^a}) versus doxorubicin in the treatment of advanced or metastatic soft tissue sarcoma: a study by the EORTC Soft Tissue and Bone Sarcoma Group",

author = "I Judson and JA Radford and M Harris and JY Blay and {van Hoesel}, Q and {le Cesne}, A and {van Oosterom}, AT and MJ Clemons and C Kamby and C Hermans and J Whittaker and {Donato di Paola}, E and Jaap Verweij and S Nielsen",

year = "2001",

language = "Undefined/Unknown",

volume = "37",

pages = "870--877",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "Elsevier Ltd.",

}

Judson, I, Radford, JA, Harris, M, Blay, JY, van Hoesel, Q, le Cesne, A, van Oosterom, AT, Clemons, MJ, Kamby, C, Hermans, C, Whittaker, J, Donato di Paola, E, Verweij, J & Nielsen, S 2001, 'Randomised phase II trial of pegylated liposomal doxorubicin (Doxilâ/Caelyxâ) versus doxorubicin in the treatment of advanced or metastatic soft tissue sarcoma: a study by the EORTC Soft Tissue and Bone Sarcoma Group', European Journal of Cancer, vol. 37, pp. 870-877.

Randomised phase II trial of pegylated liposomal doxorubicin (Doxilâ/Caelyxâ) versus doxorubicin in the treatment of advanced or metastatic soft tissue sarcoma: a study by the EORTC Soft Tissue and Bone Sarcoma Group. / Judson, I; Radford, JA; Harris, M et al.
In: European Journal of Cancer, Vol. 37, 2001, p. 870-877.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Randomised phase II trial of pegylated liposomal doxorubicin (Doxilâ/Caelyxâ) versus doxorubicin in the treatment of advanced or metastatic soft tissue sarcoma: a study by the EORTC Soft Tissue and Bone Sarcoma Group

AU - Judson, I

AU - Radford, JA

AU - Harris, M

AU - Blay, JY

AU - van Hoesel, Q

AU - le Cesne, A

AU - van Oosterom, AT

AU - Clemons, MJ

AU - Kamby, C

AU - Hermans, C

AU - Whittaker, J

AU - Donato di Paola, E

AU - Verweij, Jaap

AU - Nielsen, S

PY - 2001

Y1 - 2001

M3 - Article

SN - 0959-8049

VL - 37

SP - 870

EP - 877

JO - European Journal of Cancer

JF - European Journal of Cancer

ER -